Lana M Rossiter from Gaithersburg, MD, age 53

Resumes

Branch Chief

view source

Location:

Washington, DC

Industry:

Public Policy

Work:

FDA - Rockville, MD since Oct 2011
Chemist
Drath's Corporation Sep 2010 - Oct 2011
Scientist
AMRI Jan 2000 - May 2010
Senior Research Chemist/Senior Research Scientist
Eli Lilly and Company Jan 1999 - Aug 2000
Postdoctoral Fellow
University of Oregon Sep 1993 - Jan 1998
Graduate Research

Education:

University of Oregon 1993 - 1998
M.S, Chemistry University of Oregon 1993 - 1998
Ph.D, Organic Chemistry Emory University 1991 - 1992
B.S., Chemistry Oxford College of Emory University 1989 - 1991
A.A., general Etowah High School 1985 - 1989

Skills:

Organic Chemistry
Chemistry
Organometallic Chemistry
Medicinal Chemistry
Organic Synthesis
Technology Transfer
Chromatography
Drug Discovery
Hplc
Science
Nmr
R&D
Polymers

Languages:

English

Lana Rossiter

view source

Us Patents

Styrenyl Derivative Compounds For Treating Ophthalmic Diseases And Disorders
view source
US Patent:

20090170841, Jul 2, 2009
Filed:

Apr 21, 2008
Appl. No.:

12/107040
Inventors:

Ian Leslie Scott - Monroe WA, US
Vladimir Aleksandrovich Kuksa - Seattle WA, US
Anna Gall - Woodinville WA, US
Mark W. Orme - Seattle WA, US
Jennifer Gage - Kenmore WA, US
Qin Jiang - Latham NY, US
Lana Michele Rossiter - Clifton Park NY, US
Ryo Kubota - Seattle WA, US
Assignee:

Acucela Inc. - Bothell WA
International Classification:

A61K 31/5375
C07C 211/02
A61K 31/135
A61K 31/40
A61K 31/445
A61K 31/495
A61K 31/164
A61P 25/00
C07C 233/01
C07C 237/02
C07D 241/04
C07D 211/06
C07D 207/04
C07D 295/00
US Classification:

5142312, 564374, 514654, 544106, 548578, 514408, 546192, 514317, 544403, 51425212, 564193, 514626, 564341
Abstract:

The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are styrenyl derivative compounds, including but not limited to stilbene derivative compounds, and compositions comprising these compounds, that are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease.

Inhibitors Of Fatty Acid Binding Protein
view source
US Patent:

20120122837, May 17, 2012
Filed:

Sep 23, 2011
Appl. No.:

13/242426
Inventors:

CLIFFORD CHENG - CAMBRIDGE MA, US
XIAOHUA HUANG - BROOKLINE MA, US
YING HUANG - BERKELEY HEIGHTS NJ, US
NING SHAO - WATCHUNG NJ, US
ASHWIN RAO - MORGANVILLE NJ, US
ANANDAN PALANI - BRIDGEWATER NJ, US
PETER ORTH - NEW YORK NY, US
JOHANNES H. VOIGT - CRANFORD NJ, US
ROBERT J. HERR - VOORHEESVILLE NY, US
LANA MICHELE ROSSITER - CLIFTON PARK NY, US
QI ZENG - DELMAR NY, US
XIANFENG SUN - GUILDERLAND NY, US
International Classification:

A61K 31/498
A61K 31/5377
A61K 31/4709
C07D 413/06
A61K 31/506
C07D 471/04
C07D 403/06
C07D 401/14
A61K 31/4985
C07D 403/14
C07D 241/44
A61P 3/04
A61P 3/10
A61P 9/10
A61P 3/06
A61K 31/55
US Classification:

51421018, 51421705, 5142348, 514249, 514312, 540599, 544116, 544295, 544350, 544354, 546157
Abstract:

The present invention relates to novel heterocyclic compounds as Fatty Acid Binding Protein (“FABP”) inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose.

Styrenyl Derivative Compounds For Treating Ophthalmic Diseases And Disorders
view source
US Patent:

20120129860, May 24, 2012
Filed:

Jan 27, 2012
Appl. No.:

13/360285
Inventors:

Ian Leslie Scott - Monroe WA, US
Vladimir Aleksandrovich Kuksa - Seattle WA, US
Anna Gall - Woodinville WA, US
Mark W. Orme - Seattle WA, US
Jennifer Gage - Kenmore WA, US
Qin Jiang - Latham NY, US
Lana Michele Rossiter - Clifton Park NY, US
Ryo Kubota - Seattle WA, US
Assignee:

Acucela, Inc. - Bothell WA
International Classification:

A61K 31/5375
C07D 295/03
C07C 323/32
C07C 317/32
C07C 237/20
A61K 31/137
A61K 31/40
A61K 31/4453
A61K 31/495
A61K 31/145
A61K 31/167
C12N 5/079
A61P 27/02
A61P 27/10
C07C 211/27
US Classification:

5142395, 564374, 544178, 548578, 546192, 544403, 564341, 564194, 514654, 514408, 514317, 51425212, 514649, 514626, 435375
Abstract:

The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are styrenyl derivative compounds, including but not limited to stilbene derivative compounds, and compositions comprising these compounds, that are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease.

Styrenyl Derivative Compounds For Treating Ophthalmic Diseases And Disorders
view source
US Patent:

20130253064, Sep 26, 2013
Filed:

Mar 7, 2013
Appl. No.:

13/789259
Inventors:

Ian Leslie Scott - Monroe WA, US
Vladimir Aleksandrovich Kuksa - Seattle WA, US
Anna Gall - Woodinville WA, US
Mark W. Orme - Seattle WA, US
Jennifer Gage - Kenmore WA, US
Qin Jiang - Latham NY, US
Lana Michele Rossiter - Clifton Park NY, US
Ryo Kubota - Seattle WA, US
International Classification:

C07C 211/27
C07C 225/06
C07C 217/62
C07C 215/08
C07C 217/10
US Classification:

514651, 514654, 514653
Abstract:

The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are styrenyl derivative compounds, including but not limited to stilbene derivative compounds, and compositions comprising these compounds, that are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease.

Styrenyl Derivative Compounds For Treating Ophthalmic Diseases And Disorders
view source
US Patent:

20160193160, Jul 7, 2016
Filed:

Mar 16, 2016
Appl. No.:

15/072250
Inventors:

- Seattle WA, US
Vladimir Aleksandrovich Kuksa - Seattle WA, US
Anna Gall - Woodinville WA, US
Mark W. Orme - Seattle WA, US
Jennifer Gage - Kenmore WA, US
Qin Jiang - Latham NY, US
Lana Michele Rossiter - Clifton Park NY, US
Kevin F. McGee - Niskayuna NY, US
Ryo Kubota - Seattle WA, US
International Classification:

A61K 31/137
Abstract:

The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are styrenyl derivative compounds, including but not limited to stilbene derivative compounds, and compositions comprising these compounds, that are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease.

Styrenyl Derivative Compounds For Treating Ophthalmic Diseases And Disorders
view source
US Patent:

20150238497, Aug 27, 2015
Filed:

Feb 25, 2015
Appl. No.:

14/631711
Inventors:

- Seattle WA, US
Vladimir Aleksandrovich Kuksa - Seattle WA, US
Anna Gall - Woodinville WA, US
Mark W. Orme - Seattle WA, US
Jennifer Gage - Kenmore WA, US
Qin Jiang - Latham NY, US
Lana Michele Rossiter - Clifton Park NY, US
Ryo Kubota - Seattle WA, US
International Classification:

A61K 31/5375
A61K 31/40
A61K 31/145
A61K 31/495
A61K 31/167
A61K 31/137
A61K 31/4453
Abstract:

The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are styrenyl derivative compounds, including but not limited to stilbene derivative compounds, and compositions comprising these compounds, that are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease.

Styrenyl Derivative Compounds For Treating Ophthalmic Diseases And Disorders
view source
US Patent:

20150166494, Jun 18, 2015
Filed:

Feb 25, 2015
Appl. No.:

14/630889
Inventors:

- Seattle WA, US
Vladimir Aleksandrovich Kuska - Seattle WA, US
Anna Gall - Woodinville WA, US
Mark W. Orme - Seattle WA, US
Jennifer Gage - Kenmore WA, US
Qin Jiang - Latham NY, US
Lana Michele Rossiter - Clifton Park NY, US
Ryo Kubota - Seattle WA, US
International Classification:

C07D 295/03
C07C 237/04
C07C 323/25
C07C 211/27
Abstract:

The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are styrenyl derivative compounds, including but not limited to stilbene derivative compounds, and compositions comprising these compounds, that are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease.

Styrenyl Derivative Compounds For Treating Ophthalmic Diseases And Disorders
view source
US Patent:

20150166495, Jun 18, 2015
Filed:

Feb 25, 2015
Appl. No.:

14/630897
Inventors:

- Seattle WA, US
Vladimir Aleksandrovich Kuska - Seattle WA, US
Anna Gall - Woodinville WA, US
Mark W. Orme - Seattle WA, US
Jennifer Gage - Kenmore WA, US
Qin Jiang - Latham NY, US
Lana Michele Rossiter - Clifton Park NY, US
Ryo Kubota - Seattle WA, US
International Classification:

C07D 295/03
C07C 323/33
C07D 211/14
C07C 237/04
C07C 211/27
C07D 207/06
Abstract:

The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are styrenyl derivative compounds, including but not limited to stilbene derivative compounds, and compositions comprising these compounds, that are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease.